Inoculum size and traits of the infecting clinical strain define the protection level against Mycobacterium tuberculosis infection in a rabbit model

European Journal of Immunology
Liana TsenovaSelvakumar Subbian

Abstract

Host protective immunity against pathogenic Mycobacterium tuberculosis (Mtb) infection is variable and poorly understood. Both prior Mtb infection and BCG vaccination have been reported to confer some protection against subsequent infection and/or disease. However, the immune correlates of host protection with or without BCG vaccination remain poorly understood. Similarly, the host response to concomitant infection with mixed Mtb strains is unclear. In this study, we used the rabbit model to examine the host response to various infectious doses of virulent Mtb HN878 with and without prior BCG vaccination, as well as simultaneous infection with a mixture of two Mtb clinical isolates HN878 and CDC1551. We demonstrate that both the ability of host immunity to control pulmonary Mtb infection and the protective efficacy of BCG vaccination against the progression of Mtb infection to disease is dependent on the infectious inoculum. The host response to infection with mixed Mtb strains mirrors the differential responses seen during infection with each of the strains alone. The protective response mounted against a hyperimmunogenic Mtb strain has a limited impact on the control of disease caused by a hypervirulent strain. This preclinic...Continue Reading

References

Aug 21, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·C R BradenJ T Crawford
Jan 1, 2004·American Journal of Respiratory and Critical Care Medicine·Robin M WarrenPaul D van Helden
Jul 20, 2005·The Journal of Infectious Diseases·Amy K BarczakClifton E Barry
Mar 23, 2006·Infection and Immunity·Liana TsenovaGilla Kaplan
May 15, 2008·BioTechniques·Ralf-Harto HübnerBurkhard Bewig
Jun 19, 2010·American Journal of Respiratory and Critical Care Medicine·Benjamin M N KaginaUNKNOWN other members of the South African Tuberculosis Vaccine Initiative
Oct 16, 2010·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·J-Y WangUNKNOWN TAMI Group
Jan 28, 2012·Cell Communication and Signaling : CCS·Mi-Sun KooGilla Kaplan
Mar 2, 2012·Journal of Clinical Microbiology·Mai N T HuyenDick van Soolingen
May 31, 2012·Open Biology·Selvakumar SubbianGilla Kaplan
Sep 11, 2012·The American Journal of Pathology·Selvakumar SubbianGilla Kaplan
Mar 2, 2013·Cell Communication and Signaling : CCS·Selvakumar SubbianGilla Kaplan
Apr 4, 2013·Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases·Adrian MuwongeTone B Johansen
Aug 21, 2013·Cell Communication and Signaling : CCS·Selvakumar SubbianGilla Kaplan
Aug 28, 2014·Journal of Medical Microbiology·Selvakumar SubbianGilla Kaplan
Jan 16, 2015·Clinical and Vaccine Immunology : CVI·Kamlesh BhattPadmini Salgame
Sep 10, 2015·International Journal of Epidemiology·Rufaro KashanguraPaul Garner
Oct 7, 2015·Seminars in Immunopathology·Anca Dorhoi, Stefan H E Kaufmann
Oct 12, 2016·Microbiology Spectrum·Juliet C Peña, Wen-Zhe Ho
May 20, 2017·Frontiers in Microbiology·Lingjun ZhanChuan Qin
Jan 18, 2018·Respirology : Official Journal of the Asian Pacific Society of Respirology·Bingdong ZhuYing Zhang
Mar 4, 2018·The Journal of Experimental Medicine·Lu HuangDavid G Russell
Jul 12, 2018·The New England Journal of Medicine·Elisa NemesUNKNOWN C-040-404 Study Team
Jul 20, 2018·Clinical Microbiology Reviews·Paul K DrainDavid R Sherman
Aug 8, 2018·The Indian Journal of Medical Research·Amit Kumar Singh, Umesh D Gupta
Oct 4, 2018·The New England Journal of Medicine·Olivier Van Der MeerenDereck R Tait
Aug 7, 2019·Journal of Clinical Medicine·Afsal KolloliSelvakumar Subbian

❮ Previous
Next ❯

Citations

Apr 3, 2021·Frontiers in Cellular and Infection Microbiology·Hee-Jeong YangLaura E Via

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.